Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85,221Revenue (TTM) $M16,551Net Margin (%)33.9Altman Z-Score10.5
Enterprise Value $M82,451EPS (TTM) $2.2Operating Margin %43.3Piotroski F-Score5
P/E(ttm)15.5Beneish M-Score-2.9Pre-tax Margin (%)42.8Higher ROA y-yN
Price/Book13.010-y EBITDA Growth Rate %19.2Quick Ratio1.0Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %17.3Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow14.6y-y EBITDA Growth Rate %11.6ROA % (ttm)42.4Higher Current Ratio y-yN
Dividend Yield %4.2PEG0.9ROE % (ttm)88.8Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M2,550ROIC % (ttm)143Gross Margin Increase y-yN

Gurus Latest Trades with NVO

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

NVO is held by these investors:

NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVO :

Quarterly/Annual Reports about NVO:

    News about NVO:

    Articles On GuruFocus.com
    New Features: Individual Portfolio Tracker and Value Screens Tracker Mar 03 2017 
    While Big Diabetes Stagnates, Smaller Companies Are Moving Faster Than Ever Feb 09 2017 
    Beaten-Down Valuation and a 3% Dividend Yield Feb 07 2017 
    Value Screeners Identify Top Sectors Feb 06 2017 
    7 Stocks for 2017 Jan 20 2017 
    Something Strange Is Going On With Oral Insulin Dec 23 2016 
    Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
    23 Questions With Thomas Macpherson of Nintai Partners Nov 21 2016 
    Graham's 4 Vital Elements Nov 10 2016 
    World Leader in Diabetes Medication Hits 2-Year Low Nov 07 2016 

    More From Other Websites
    Novo Nordisk Stock Trades Ex-Dividend Thursday Mar 22 2017
    A drug company just struck a deal to discount the price of a lifesaving diabetes medication to $25 Mar 16 2017
    Sanofi and Voluntis Ink Global Pact for Diabetes Mar 15 2017
    Novo Nordisk's Diabetes Unit Strong; Generic Pressure Stays Mar 13 2017
    SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Novo Nordisk... Mar 11 2017
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo... Mar 10 2017
    Adam Feuerstein Weighs In On Novo-GBT Rumors, Undue Sarepta Volatility, Unprofitable Business Of... Mar 10 2017
    INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action... Mar 10 2017
    Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors Mar 10 2017
    Biotech Reporter Adam Feuerstein Will Be On Benzinga's PreMarket Prep Friday Morning Mar 09 2017
    Novo Nordisk in Talks to Buy Global Blood Therapeutics (NVO,GBT) Mar 09 2017
    March 13 Deadline Alert: Law Offices of Howard G. Smith Reminds Novo Nordisk A/S Investors of... Mar 09 2017
    DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo... Mar 09 2017
    Novo Nordisk Named on the FORTUNE 100 Best Companies to Work For® List for Ninth Consecutive Year Mar 09 2017
    Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk Mar 08 2017
    Novo Nordisk in bid for Global Blood Therapeutics - sources Mar 08 2017
    INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action... Mar 08 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)